Observational Retrospective and Prospective Study on the Treatment of Femoral Fractures With EBA2
NCT ID: NCT01599221
Last Updated: 2012-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2012-03-31
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is aimed at collecting data from patients who have already been treated with EBA2 nail. Data collection will cover the details of the fracture and surgery (from which the retrospective nature of the study), as well as details of follow up visits after surgery that patients routinely carry out up to 6 months (from which the prospective nature of the study).
The study will be conducted in three clinical sites in Italy.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* it is undersized compared to other nails in commerce, both proximal and distal, to further facilitate the insertion into the bone. The undersizing is aimed to reduce the stiffness of the stem. In particular, the biological nail-bone interaction will be improved as a consequence of lower shear stresses on the frontal plane;
* it is made entirely of titanium. The choice of such a material is aimed to create a flexible means of synthesis that minimizes the differences with the healthy bone mechanical properties and reduces complications in the process of fracture healing;
* it is a dual-lag screw system that provides appropriate guidance to the sliding of the fractured extremities and an improved stability. It is effective to limit torsional instability of the femoral head, both during the intervention, by the action of tightening of the screw itself, and during the healing period due to improved bearing capacity towards multidirectional loads;
* the associated surgical instruments are simple; the low number of pieces and their ease of use made the success even of the previous version.
The aim of the present observational study is to collect data that confirm for EBA2, the technological evolution of Endovis BA, the performance and tolerability proved in the previous trial. In addition, given the increasing importance that good quality of life represents in elderly, objective of this observational study is to verify the general satisfaction of the patient with lateral proximal femoral fractures treated with EBA2.
In order to evaluate subject's walking ability after the surgical insertion of EBA2, only subjects who could walk independently before of the fracture will be included in this observational study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects with EBA2
Subjects who have undergone surgery with EBA2 medical device for lateral proximal femoral fractures
EBA2
Surgical implantation of EBA2 medical device in subjects with lateral proximal femoral fractures treated
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EBA2
Surgical implantation of EBA2 medical device in subjects with lateral proximal femoral fractures treated
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects with diagnosed lateral proximal femoral fractures who have undergone surgery with EBA2 nail;
* Subjects with type 31A1, 31A2 or 31A3 fractures;
* Subjects able to walk independently (with or without walking aids) before the fracture;
* Subjects who sustained a low energy injury within 72 h prior the surgery;
* Subjects who received a perioperative antibiotic therapy;
* Subjects who received antithrombotic prophylaxis for 5 weeks;
* Subjects who underwent rehabilitation procedure for 30 days at least;
* Subjects who have been mobilized in the 2nd operation day;
* Subjects able to attend the scheduled visits and to follow the instructions given by the physician;
* Subjects who have given their written informed consent.
Exclusion Criteria
* Subjects with fractures due to metastasis;
* Subjects with fractures operated 72 h after the traumatic event;
* Subjects with previous ipsilateral hip or femur surgery;
* Subjects with ASA Physical Status Classification Class 5;
* Subjects with Karnofsky performance status scale before fracture ˂ 80;
* Subjects who have shown hypersensitivity to any of the components of EBA2;
* Concomitant use of any other surgical device for the femoral fracture.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Opera CRO, a TIGERMED Group Company
OTHER
Citieffe S.r.l
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vincenzo Caiaffa, MD
Role: PRINCIPAL_INVESTIGATOR
S.C. Ortopedia e Traumatologia - P.O. Centrale "SS. Annunziata" ASL Taranto - Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Ospedaliero-Universitaria Consorziale Policlinico
Bari, , Italy
Unità operativa complessa di Ortopedia e Traumatologia - AUSL 12 di Viareggio
Lido di Camaiore, , Italy
S.C. Ortopedia e Traumatologia - P.O. Centrale SS. Annunziata
Taranto, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Papasimos S, Koutsojannis CM, Panagopoulos A, Megas P, Lambiris E. A randomised comparison of AMBI, TGN and PFN for treatment of unstable trochanteric fractures. Arch Orthop Trauma Surg. 2005 Sep;125(7):462-8. doi: 10.1007/s00402-005-0021-5.
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007 Mar;22(3):465-75. doi: 10.1359/jbmr.061113.
Zain Elabdien BS, Olerud S, Karlstrom G. The influence of age on the morphology of trochanteric fracture. Arch Orthop Trauma Surg (1978). 1984;103(3):156-61. doi: 10.1007/BF00435546.
Cummings SR, Nevitt MC. A hypothesis: the causes of hip fractures. J Gerontol. 1989 Jul;44(4):M107-11. doi: 10.1093/geronj/44.4.m107.
Caiaffa V, De Vita D, Laforgia R, Sessa G, Varsalona R, Girolami M, Dallari D, Mignani G, Turi G, Micaglio A, et al. Treatment of peritrochanteric fractures with the Endovis BA cephalomedullary nail: multicenter study of 1091 patients Journal of Orthopaedics and Traumatology 8(3): 111-116, 2007
Haidukewych GJ, Israel TA, Berry DJ. Reverse obliquity fractures of the intertrochanteric region of the femur. J Bone Joint Surg Am. 2001 May;83(5):643-50. doi: 10.2106/00004623-200105000-00001.
Olsson O, Ceder L, Hauggaard A. Femoral shortening in intertrochanteric fractures. A comparison between the Medoff sliding plate and the compression hip screw. J Bone Joint Surg Br. 2001 May;83(4):572-8. doi: 10.1302/0301-620x.83b4.11302.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EBA2
Identifier Type: -
Identifier Source: org_study_id